Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Alyssa Milano has gone under the knife to return to her "authentic self." The "Charmed" alumna, 52, on Sept. 24 shared a photo of herself on Instagram donning a hospital gown and a hairnet, explaining ...

People with tooth loss or older adults can use dental implants to replace natural teeth. Despite a minor complication risk and higher upfront cost, implants often outlast alternative solutions.

Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core segments. Despite a 20% share price drop, I see upside potential, ...

A team from Fudan University, the Shanghai Institute of Technical Physics, the Beijing University of Posts and Telecommunications and Shaoxin Laboratory, all in China, has developed a retinal ...

Coloplast's stock price has declined by 25% since April 2023, making it more attractive but still overvalued based on fundamentals and valuation multiples. Recent quarterly results show revenue growth ...

UAMS announced Tuesday that it's a Center of Excellence for the AMS 700 Inflatable Penile Prosthesis. Credit: Boston Scientific The University of Arkansas for Medical Sciences announced Tuesday that ...

Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue in DKK grew 6% and included negative impact from the divestment of Skin Care and ...